Asana Insider Files to Sell $181k in Stock Under Rule 144

Rhea-AI Filing Summary

Asana, Inc. (ticker ASAN) filed a Form 144 indicating a proposed disposition of insider-held shares under Rule 144. The notice covers the sale of 13,760 common shares through broker Morgan Stanley Smith Barney on or about 23 June 2025 on the NYSE. The shares carry an aggregate market value of approximately $180,944, based on the price at the time of filing. With 155,760,507 shares outstanding, the transaction represents roughly 0.009 % of the company’s total common stock, indicating limited dilution or market-moving potential.

The filing also discloses that the same account holder (name not listed in the excerpt) previously sold 4,911 shares for gross proceeds of $73,085.01 on 24 March 2025. The securities being sold were acquired as Restricted Stock Units on 20 June 2025, with no cash consideration indicated, suggesting they stem from equity compensation. No adverse information about the issuer was acknowledged, and no details were provided on a Rule 10b5-1 trading plan. While insider sales can raise sentiment concerns, the amount is immaterial relative to Asana’s float and unlikely to affect corporate strategy or liquidity.

Positive

• None.

Negative

• Insider intends to sell 13,760 shares ($180,944), potentially signaling limited confidence, though the amount is small.
• Additional 4,911 shares sold in March 2025 indicates ongoing liquidation of insider holdings.

Insights

Financial Analyst

TL;DR: Small insider sale (0.009 % float) appears immaterial; signals routine diversification rather than strategic shift.

The Form 144 shows an insider looking to sell 13,760 shares worth about $181k. Relative to Asana’s 155.8 million shares outstanding, the sale is negligible and unlikely to pressure the stock. The shares were recently vested RSUs, a common liquidity event for employees and executives. A prior 4,911-share sale in March supports a pattern of periodic selling rather than a single large exit. No earnings, guidance, or operational updates accompany the filing, so the fundamental outlook remains unchanged. Overall market impact: neutral.

Corporate Governance Expert

TL;DR: Continued insider selling warrants monitoring, but scale too small to raise governance red flags.

Repeated sales over a three-month span suggest the insider is monetizing compensation grants, which is typical for technology issuers relying on equity packages. The absence of a declared 10b5-1 plan reduces automatic-trade transparency, but the filing certifies no undisclosed adverse information. Given immaterial volume, shareholders are unlikely to question board oversight or executive commitment. Nevertheless, investors may wish to track cumulative insider activity for trend changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13760	180944.00	155760507	06/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/20/2025	Restricted Stock Units	Issuer			13760	06/20/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ELEANOR LACEY 633 FOLSOM STREET SUITE 100 SAN FRANCISCO CA 94107	Common	03/24/2025	4911	73085.01

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Asana (ASAN) shares are being sold under this Form 144?

The filing covers 13,760 common shares of Asana.

What is the aggregate market value of the proposed sale?

The shares are valued at approximately $180,944 based on the market price at filing time.

When is the anticipated sale date for the shares?

The approximate sale date disclosed is June 23, 2025.

How many Asana shares are outstanding compared with the shares being sold?

Asana has 155,760,507 shares outstanding, so the sale represents roughly 0.009 % of total shares.

Were any shares sold by the same insider in the past three months?

Yes. 4,911 shares were sold on March 24, 2025 for gross proceeds of $73,085.01.